1Valero V, Jones SE, Von Hoff DD, et al. A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer [J]. J Clin Oncol, 1998, 16 (10) : 3362 - 3368.
2Taguchi T, Aihara T, Takatsuka Y, et al. Phase 11 Study of Weekly Paelitaxel for Docetaxel-Resistant Metastatic Breast Cancer in Japan [J]. Breast J, 2004, 10 (6): 509 -513.
3徐冰河,孙燕.乳腺癌内科治疗的策略及研究[J].乳腺病杂志,2003,1(1):1-3.
4Nabholtz JM, Tonkin K, Smylie M, et al. Chemotherapy of breast cancer: Are the taxanesgoing to change the natural history of breast cancer [ J ]. Expert Opin Pharmacother, 20001 (2): 187 -206.
6Hanauske AR, Degen D, Hilsenbeck SG, et al. Effects of Taxotere and Taxol on invitro colony formation of freshly ex- planted human tumor cells [J]. Anti-cancer Drugs, 1992, 3 (2):121-124.
7Riou JF, Naudin A, Lavelle F. Effects of Taxotere on mu- rine and human tumor cell lines [ J ]. Bioehem Biophys Res Commun, 1992, 187 (1) : 164 - 170.
8Diaz JF, Andreu JM. Assembly of purified GDP-tubulin intomicrotubules induced by Taxol and Taxotere: Reversibility, ligand stoichiometry, and competition [ J ]. Biochemistry, 1993, 32 ( 11 ) : 2747 - 2755.
9Ringel I, Horwitz SB. Studies with RP 56976 (Taxotere) : A semisynthetic analogue of Taxol [ J]. J Natl Cancer Inst, 1991, 83 (4):288-291.
10Andreu JM, Diaz JF, Gil R, et al. Solution structure of Taxotere-induced microtubules to 3nm resolution [ J ]. J Biol Chem, 1994, 269:31785 -31792.
